. .
Français
France
Livres similaires
Autres livres qui pourraient ressembler au livre recherché:
Outils de recherche
s'inscrire

Connectez-vous avec Facebook:

S'inscrire
Mot de passe oublié?


Historique de recherche
Liste pense-bête
Liens vers eurolivre.fr

Partager ce livre sur…
Livre conseillé
Actualités
Conseils d'eurolivre.fr
Publicité
FILTRE
- 0 Résultats
prix le plus bas: 149,75 €, prix le plus élevé: 196,34 €, prix moyen: 169,17 €
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff
Livre non disponible
(*)
Ingo K. Mellinghoff:
Therapeutic Kinase Inhibitors - nouveau livre

ISBN: 9783642282966

ID: 9783642282966

Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as chemotherapy and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5&apos -triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates.  This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert. Therapeutic Kinase Inhibitors: Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as chemotherapy and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5&apos -triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates.  This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert. Krebs (Krankheit) Tumor / Krebs MEDICAL / Oncology, Springer-Verlag Gmbh

Nouveaux livres Rheinberg-Buch.de
Ebook, Englisch, Neuware Frais d'envoiAb 20¤ Versandkostenfrei in Deutschland, Sofort lieferbar, DE. (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff, Charles L. Sawyers
Livre non disponible
(*)
Ingo K. Mellinghoff, Charles L. Sawyers:
Therapeutic Kinase Inhibitors - nouveau livre

ISBN: 9783642282966

ID: 501611

Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as “chemotherapy” and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert., [PU: Springer, Berlin/Heidelberg/New York, NY]

Nouveaux livres Ciando.de
ciando.de
http://www.ciando.com/img/books/3642282962_k.jpg, E-Book zum Download Frais d'envoiVersandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Therapeutic Kinase Inhibitors - Mellinghoff, Ingo K.; Sawyers, Charles L.
Livre non disponible
(*)
Mellinghoff, Ingo K.; Sawyers, Charles L.:
Therapeutic Kinase Inhibitors - nouveau livre

2012, ISBN: 3642282962

ID: 9783642282966

In englischer Sprache. Verlag: Springer Berlin, Preface.- Fundamentals.- Setting up a Kinase Discovery and Development Project.-Drug Efficacy Testing in Mice.- Kinase Targets and Disease.- Gastrointestinal Stromal Tumors (GISTS).-EGFR-Mutant Lung Cancer.- Targeting Oncogenic BRAF in Human Cancer.- Beyond BRAF in Melanoma.- JAK-mutant Myeloproliferative Neoplasms.- Will Kinase Inhibitors Make It as Glioblastoma Drugs?.- Perspectives.- Predictive Genomic Biomarkers.- Epigenetic Biomarkers.- Adjuvant Trials of Targeted Agents: The Newest Battleground in the War on Cancer.- Subject Index, PC-PDF, 234 Seiten, X Seiten, 234 Seiten, [GR: 9692 - Nonbooks, PBS / Medizin/Nichtklinische Fächer], [SW: - Vorklinische Medizin, Grundlagenwissenschaften], [Ausgabe: 2012][PU:Springer Berlin], [PU: Springer, Berlin/Heidelberg/New York, NY]

Nouveaux livres Libreka.de
Libreka
Frais d'envoiLivraison non-comprise
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Therapeutic Kinase Inhibitors - Mellinghoff, Ingo K.; Sawyers, Charles L.
Livre non disponible
(*)
Mellinghoff, Ingo K.; Sawyers, Charles L.:
Therapeutic Kinase Inhibitors - nouveau livre

2012, ISBN: 3642282962

ID: 9783642282966

In englischer Sprache. Verlag: Springer Berlin, PC-PDF, 234 Seiten, X Seiten, 234 Seiten, 1., 2012, [GR: 9692 - Nonbooks, PBS / Medizin/Nichtklinische Fächer], [SW: - Vorklinische Medizin, Grundlagenwissenschaften], [Ausgabe: 1], [PU: Springer, Berlin/Heidelberg/New York, NY]

Nouveaux livres Libreka.de
Libreka
Frais d'envoiVersandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff;  Ingo K. Mellinghoff;  Charles L. Sawyers;  Charles L. Sawyers
Livre non disponible
(*)
Ingo K. Mellinghoff; Ingo K. Mellinghoff; Charles L. Sawyers; Charles L. Sawyers:
Therapeutic Kinase Inhibitors - Première édition

2012, ISBN: 9783642282966

ID: 26615767

[ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]

Nouveaux livres Lehmanns.de
Frais d'envoiDownload sofort lieferbar, , Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.

Détails sur le livre
Therapeutic Kinase Inhibitors
Auteur:

Ingo K. Mellinghoff;Charles L. Sawyers

Titre:

Therapeutic Kinase Inhibitors

ISBN:

Informations détaillées sur le livre - Therapeutic Kinase Inhibitors


EAN (ISBN-13): 9783642282966
ISBN (ISBN-10): 3642282962
Date de parution: 2012
Editeur: Springer Berlin
234 Pages
Langue: eng/Englisch

Livre dans la base de données depuis 03.12.2012 21:22:03
Livre trouvé récemment le 10.02.2017 10:01:59
ISBN/EAN: 9783642282966

ISBN - Autres types d'écriture:
3-642-28296-2, 978-3-642-28296-6


< pour archiver...
Livres en relation